Document Detail


[Lichen planus-like eruption. Case report].
MedLine Citation:
PMID:  20191882     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cutaneous adverse drug reactions are among the most common adverse drug reactions. Thise reactions to drugs can comprise a broad spectrum of clinical and histopathological features, with an important capacity to mimic numerous dermatological diseases, making the diagnose very difficult. We present the case of a patient, under immunomodulating treatment (TNFalpha antagonist and leflunomide), with a muco-cutaneous lichen planus-like eruption.
Authors:
Laura Stătescu; Delia Ciobanu; Georgiana Mihăilă; C Stătescu; Laura Gheucă Solovăstru
Publication Detail:
Type:  Case Reports; English Abstract; Journal Article    
Journal Detail:
Title:  Revista medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti din Iaş̧i     Volume:  113     ISSN:  0048-7848     ISO Abbreviation:  Rev Med Chir Soc Med Nat Iasi     Publication Date:    2009 Oct-Dec
Date Detail:
Created Date:  2010-03-02     Completed Date:  2010-05-14     Revised Date:  2011-01-13    
Medline Journal Info:
Nlm Unique ID:  0413735     Medline TA:  Rev Med Chir Soc Med Nat Iasi     Country:  Romania    
Other Details:
Languages:  rum     Pagination:  1102-6     Citation Subset:  IM    
Affiliation:
Disciplina de Dermatologie, Facultatea de Medicină, Universitatea de Medicină si Farmacie "Gr.T. Popa" Iaşi.
Vernacular Title:
Erupţie lichenoidă postmedicamentoasă.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Monoclonal / administration & dosage,  adverse effects*
Antirheumatic Agents / administration & dosage,  adverse effects*
Arthritis, Psoriatic / drug therapy
Diagnosis, Differential
Female
Humans
Immunosuppressive Agents / administration & dosage,  adverse effects*
Isoxazoles / administration & dosage,  adverse effects*
Lichen Planus / chemically induced*,  drug therapy,  pathology*
Middle Aged
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Antirheumatic Agents; 0/Immunosuppressive Agents; 0/Isoxazoles; 0/infliximab; 75706-12-6/leflunomide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  [Toxocariasis respiratory manifestations in cases hospitalized in the Paediatric Diseases Clinic of ...
Next Document:  Nephrotic syndrome from the genetic point of view.